Nordic Pharma Lab ApS: Financial statements 2023
CVR: 39161672
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -18,791 and a net result of DKK -28,302 compared with DKK -33,327 the year before. Equity in the 2023 report amounted to DKK -287,937.
- Gross Profit
- DKK -18,791
- Profit/Loss
- DKK -28,302
- Equity
- DKK -287,937
- Total Assets
- DKK 4,187
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -19 t. | -28 t. | -288 t. | - |
| 2022 | - | -24 t. | -33 t. | -260 t. | - |
| 2021 | - | -106 t. | -283 t. | -226 t. | - |
| 2020 | 1 | -41 t. | -20 t. | 57 t. | - |
| 2019 | - | -12 t. | -12 t. | 77 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Nordic Pharma Lab ApS has published its annual report for 2022. Gross profit came to DKK -24,146, and the net result was DKK -33,327.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.